|
|
- Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats Get a glimpse of how we work to improve lives
- Who we are - Merck. com
Merck aspires to be the premier research-intensive biopharmaceutical company in the world Learn about our commitment to save and improve lives
- Discover Job Opportunities at Merck | Merck Careers
Explore current job opportunities at Merck Learn more about careers in Business Support, Clinical, Engineering, Information Technology, Research Development, Manufacturing and Marketing
- Contact us - Merck. com
Our corporate headquarters is located at: 126 East Lincoln Avenue P O Box 2000 Rahway, NJ 07065 USA To reach a Merck employee, please call: 1-908-740-4000
- What can we help you find? - Merck
ENFLONSIA is a preventive monoclonal antibody designed to protect infants against a spectrum of RSV disease severity, including worsening disease requiring hospitalization ENFLONSIA is the first and only RSV preventive option administered to infants using the same dose regardless of weight Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U S Food
- History - Merck. com
Learn how Merck has created a legacy of inventing medicines and vaccines and become a leading global biopharmaceutical company over the past 130 years
- Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results
Fourth-Quarter Worldwide Sales Were $15 6 Billion, an Increase of 7% From Fourth Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 9% Fourth-Quarter GAAP EPS Was $1 48; Non-GAAP EPS Was $1 72; GAAP and Non-GAAP EPS Include a Charge of $0 23 per Share Related to Certain Business Development Transactions Full-Year Worldwide Sales Were $64 2 Billion, an Increase of 7% From Full
- Your job search results | Merck Careers
Forward-Looking Statement of Merck Co , Inc , Kenilworth, NJ, USA This website of Merck Co , Inc , Kenilworth, NJ, USA (the “company”) includes “forward
- What can we help you find? - Merck
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U S home for KEYTRUDA Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware A cornerstone of Merck’s continued commitment
- Patients - Merck. com
Resources for patients and caregivers to learn about our dedication to our patient communities, our financial assistance programs and our areas of focus
|
|
英文每年常用名排名
2023 年排名
2022 年排名
2021 年排名
2020 年排名
2019 年排名
2018 年排名
2017 年排名
2016 年排名
2015 年排名
2014 年排名
2013 年排名
2012 年排名
2011 年排名
2010 年排名
2009 年排名
2008 年排名
2007 年排名
2006 年排名
2005 年排名
2004 年排名
2003 年排名
2002 年排名
2001 年排名
2000 年排名
英文名字起源
希伯来
希腊
条顿
印度
拉丁
拉丁语
古英语
英格兰
阿拉伯
法国
盖尔
英语
匈牙利
凯尔特
西班牙
居尔特
非洲
美洲土著
挪威
德国
威尔士
斯拉夫民族
古德语
爱尔兰
波斯
古法语
盎格鲁撒克逊
意大利
盖尔语
未知
夏威夷
中古英语
梵语
苏格兰
俄罗斯
土耳其
捷克
希腊;拉丁
斯干那维亚
瑞典
波兰
乌干达
拉丁;条顿
巴斯克语
亚拉姆
亚美尼亚
斯拉夫语
斯堪地纳维亚
越南
荷兰
|